Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sequana Medical presents its technology platforms for treating diuretic-resistant fluid overload, including the alfapump® system under clinical investigation for refractory ascites and DSR® therapy in development. The presentation outlines the company's innovation approach and clinical programs as of January 2022.
conference
21 Pages
investor_presentation
41 Pages
GFT Technologies SE
Mrs. Bectors Food Specialities Q1 FY22 Investor Presentation
investor_presentationinvestor_presentation
32 Pages
Mrs. Bectors Food Specialities Limited
investor_presentation
AltaGas